Global economic cost of smoking-attributable diseases

BackgroundThe detrimental impact of smoking on health has been widely documented since the 1960s. Numerous studies have also quantified the economic cost that smoking imposes on society. However, these studies have mostly been in high income countries, with limited documentation from developing coun...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Tobacco control Ročník 27; číslo 1; s. 58 - 64
Hlavní autoři: Goodchild, Mark, Nargis, Nigar, Tursan d'Espaignet, Edouard
Médium: Journal Article
Jazyk:angličtina
Vydáno: England BMJ 01.01.2018
BMJ Publishing Group
Témata:
Cost of Illness
Developing Countries
Efficiency
Global Health - economics
Global Health - statistics & numerical data
Health Care Costs - statistics & numerical data
Health Expenditures - statistics & numerical data
Humans
Research Paper
Smoking - adverse effects
Smoking - economics
Economics
Global health
Smoking Caused Disease
ISSN:0964-4563, 1468-3318, 1468-3318
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:BackgroundThe detrimental impact of smoking on health has been widely documented since the 1960s. Numerous studies have also quantified the economic cost that smoking imposes on society. However, these studies have mostly been in high income countries, with limited documentation from developing countries. The aim of this paper is to measure the economic cost of smoking-attributable diseases in countries throughout the world, including in low- and middle-income settings.MethodsThe Cost of Illness approach is used to estimate the economic cost of smoking attributable-diseases in 2012. Under this approach, economic costs are defined as either ‘direct costs' such as hospital fees or ‘indirect costs’ representing the productivity loss from morbidity and mortality. The same method was applied to 152 countries, which had all the necessary data, representing 97% of the world's smokers.FindingsThe amount of healthcare expenditure due to smoking-attributable diseases totalled purchasing power parity (PPP) $467 billion (US$422 billion) in 2012, or 5.7% of global health expenditure. The total economic cost of smoking (from health expenditures and productivity losses together) totalled PPP $1852 billion (US$1436 billion) in 2012, equivalent in magnitude to 1.8% of the world's annual gross domestic product (GDP). Almost 40% of this cost occurred in developing countries, highlighting the substantial burden these countries suffer.ConclusionsSmoking imposes a heavy economic burden throughout the world, particularly in Europe and North America, where the tobacco epidemic is most advanced. These findings highlight the urgent need for countries to implement stronger tobacco control measures to address these costs.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0964-4563
1468-3318
1468-3318
DOI:10.1136/tobaccocontrol-2016-053305